Ryanodine receptor studies using genetically engineered mice.
about
Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseasesThe junctophilin family of proteins: from bench to bedsideThe Concise Guide to PHARMACOLOGY 2013/14: ion channelsRole of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease.Calcium channels in the development, maturation, and function of spermatozoa.Eccentric contractions disrupt FKBP12 content in mouse skeletal muscle.The ryanodine receptor in cardiac physiology and disease.A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila.Triadopathies: an emerging class of skeletal muscle diseases.Calcium cycling proteins and heart failure: mechanisms and therapeuticsDrosophila ryanodine receptors mediate general anesthesia by halothaneStructure-activity relationship of selected meta- and para-hydroxylated non-dioxin like polychlorinated biphenyls: from single RyR1 channels to muscle dysfunction.Ryanodine receptor patents.Endoplasmic reticulum calcium stores in dendritic spinesRoles of Calcium Stores and Store-Operated Channels in Plasticity of Dendritic Spines.Hyperthermic seizures and aberrant cellular homeostasis in Drosophila dystrophic muscles.Mechanisms of SR calcium release in healthy and failing human hearts.nNOS regulation of skeletal muscle fatigue and exercise performance.Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.
P2860
Q24336808-D01927AA-0A9B-4E41-B08E-3E3737A0EBC3Q27027609-ED144F78-D0F2-47B8-A74E-737F57AD5AEFQ30486735-F9621198-A1FD-4AC5-8B95-306BE1CF9C97Q33561848-93C54595-B8D3-47F7-BDC0-EB1E4A35DFEBQ34052215-DA6E00D7-A3AA-4A31-A679-E8FE413E758FQ34297447-7338A3A7-4177-4490-9E85-21DA52C5B6C2Q34505314-C175241F-6305-4214-AB83-EB7CCD49DF3AQ35078638-0BF42D4D-5979-4207-A128-0BC438BCA23FQ35340211-2288D334-F1FC-46A6-B381-E09F3610D80CQ36497155-C756F584-FE27-4347-8105-B43D570B4530Q36631648-50256F3E-E8B5-4EDA-B81C-5F4AEF15EBEBQ37380782-F1B8D911-978D-47DF-82B8-397743BC038BQ38054907-C98E96F5-3D69-4015-831F-316DFB9AEEE7Q38234887-02133956-ED64-4FD7-A6B0-6B2653C4059AQ38618700-89C40458-EDAA-496D-BAB4-E39F6DFF5C31Q39120000-64D79E9F-93A8-499F-BA3D-306079F40C7DQ39310132-223840E2-7DB9-449C-9BC6-0BBDDB9B5D00Q39310461-11D31667-E3DE-4A98-8971-81809952275BQ49384661-1447AAB1-BAB9-4686-8969-C8D11B4E4EF5
P2860
Ryanodine receptor studies using genetically engineered mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ryanodine receptor studies using genetically engineered mice.
@en
Ryanodine receptor studies using genetically engineered mice.
@nl
type
label
Ryanodine receptor studies using genetically engineered mice.
@en
Ryanodine receptor studies using genetically engineered mice.
@nl
prefLabel
Ryanodine receptor studies using genetically engineered mice.
@en
Ryanodine receptor studies using genetically engineered mice.
@nl
P2093
P2860
P1433
P1476
Ryanodine receptor studies using genetically engineered mice.
@en
P2093
Alexander Kushnir
Andrew R Marks
Matthew J Betzenhauser
P2860
P304
P356
10.1016/J.FEBSLET.2010.03.005
P407
P577
2010-03-07T00:00:00Z